New treatments for childhood obesity using dual hormone therapies
Efficacy of Novel Melanocortin and Gut-peptide Dual Agonists for Childhood Obesity Treatment
This study is looking at new ways to help kids and teens with obesity by creating special treatments that can help them feel less hungry and lose weight, all while being easier on their bodies than current options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Children's Hospital NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11056615 on NIH RePORTER |
What this research studies
This research investigates innovative treatments for childhood obesity by developing dual agonists that target both melanocortin and gut peptides. These therapies aim to suppress appetite and promote weight loss while minimizing side effects commonly associated with existing treatments. The approach focuses on enhancing energy expenditure and improving compliance among children and adolescents who struggle with obesity. By combining multiple mechanisms, the research seeks to provide a more effective and tolerable solution for young patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and adolescents struggling with obesity who may benefit from new treatment options.
Not a fit: Patients who are not experiencing obesity or those with conditions that contraindicate the use of hormonal therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer weight loss treatments for children and adolescents with obesity.
How similar studies have performed: Previous research has shown promise in using hormonal therapies for obesity treatment, indicating that this approach may lead to significant advancements.
Where this research is happening
Seattle, United States
- Seattle Children's Hospital — Seattle, United States (Active)
Researchers
- Principal investigator: Roth, Christian Ludwig — Seattle Children's Hospital
- Study coordinator: Roth, Christian Ludwig
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.